Complex Network Analysis of CA3 Transcriptome Reveals Pathogenic and Compensatory Pathways in Refractory Temporal Lobe Epilepsy

Carregando...
Imagem de Miniatura
Citações na Scopus
20
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Autores
SILVA, Filipi Nascimento
COSTA, Luciano Da Fontoura
SILVA, Alexandre V.
PIMENTEL-SILVA, Luciana R.
Citação
PLOS ONE, v.8, n.11, article ID e79913, 17p, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
We previously described - studying transcriptional signatures of hippocampal CA3 explants - that febrile (FS) and afebrile (NFS) forms of refractory mesial temporal lobe epilepsy constitute two distinct genomic phenotypes. That network analysis was based on a limited number (hundreds) of differentially expressed genes (DE networks) among a large set of valid transcripts (close to two tens of thousands). Here we developed a methodology for complex network visualization (3D) and analysis that allows the categorization of network nodes according to distinct hierarchical levels of gene-gene connections (node degree) and of interconnection between node neighbors (concentric node degree). Hubs are highly connected nodes, VIPs have low node degree but connect only with hubs, and high-hubs have VIP status and high overall number of connections. Studying the whole set of CA3 valid transcripts we: i) obtained complete transcriptional networks (CO) for FS and NFS phenotypic groups; ii) examined how CO and DE networks are related; iii) characterized genomic and molecular mechanisms underlying FS and NFS phenotypes, identifying potential novel targets for therapeutic interventions. We found that: i) DE hubs and VIPs are evenly distributed inside the CO networks; ii) most DE hubs and VIPs are related to synaptic transmission and neuronal excitability whereas most CO hubs, VIPs and high hubs are related to neuronal differentiation, homeostasis and neuroprotection, indicating compensatory mechanisms. Complex network visualization and analysis is a useful tool for systems biology approaches to multifactorial diseases. Network centrality observed for hubs, VIPs and high hubs of CO networks, is consistent with the network disease model, where a group of nodes whose perturbation leads to a disease phenotype occupies a central position in the network. Conceivably, the chance for exerting therapeutic effects through the modulation of particular genes will be higher if these genes are highly interconnected in transcriptional networks.
Palavras-chave
Referências
  1. Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019
  2. Alegro MD, 2012, MAGN RESON MED, V68, P1647, DOI 10.1002/mrm.24174
  3. Babbio F, 2004, CELL CYCLE, V3, P486
  4. Bae EK, 2010, J CLIN NEUROL, V6, P73, DOI 10.3988/jcn.2010.6.2.73
  5. Bai J, 2011, NEUROTOX RES, V19, P412, DOI 10.1007/s12640-010-9183-1
  6. Bando SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026268
  7. Barabasi AL, 2011, NAT REV GENET, V13, P56
  8. Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272
  9. Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030
  10. Baulac S, 2004, LANCET NEUROL, V3, P421, DOI 10.1016/S1474-4422(04)00808-7
  11. Blumcke I, 2009, ACTA NEUROPATHOL, V117, P535, DOI 10.1007/s00401-009-0512-5
  12. Bradley J, 1997, J NEUROSCI, V17, P1993
  13. Brandes U, 2001, J MATH SOCIOL, V25, P163
  14. Brooks-Kayal AR, 2012, JASPERS BASIC MECH E
  15. Cai JJ, 2010, GENOME BIOL EVOL, V2, P815, DOI 10.1093/gbe/evq064
  16. Carpio A, 2009, CURR NEUROL NEUROSCI, V9, P319, DOI 10.1007/s11910-009-0048-z
  17. Casillas-Espinosa P. M., 2012, EPILEPSIA, V9, P41, DOI 10.1111/EPI.12034
  18. Castro PA, 2002, NEUROSCIENCE, V114, P961, DOI 10.1016/S0306-4522(02)00296-8
  19. Cea-del Rio CA, 2010, J NEUROSCI, V30, P6011, DOI 10.1523/JNEUROSCI.5040-09.2010
  20. Cendes F, 2004, CURR OPIN NEUROL, V17, P161, DOI 10.1097/01.wco.0000124706.48483.da
  21. Chen J, 2013, BBA-MOL CELL BIOL L, V1831, P263, DOI 10.1016/j.bbalip.2012.09.007
  22. Chungath M, 2008, NAT CLIN PRACT NEURO, V4, P610, DOI 10.1038/ncpneuro0922
  23. Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111
  24. Costa LD, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098702
  25. Costa LD, 2008, PHYSICA A, V387, P6201, DOI 10.1016/j.physa.2008.06.034
  26. Costa LD, 2006, J STAT PHYS, V125, P845, DOI 10.1007/s10955-006-9130-y
  27. Costa LD, 2011, ADV PHYS, V60, P329, DOI 10.1080/00018732.2011.572452
  28. Dalpe G, 1998, MOL CELL NEUROSCI, V10, P243, DOI 10.1006/mcne.1997.0660
  29. Deguchi Y, 2011, NAT NEUROSCI, V14, P495, DOI 10.1038/nn.2768
  30. Dube CM, 2010, J NEUROSCI, V30, P7484, DOI 10.1523/JNEUROSCI.0551-10.2010
  31. Engel J, 2001, NEUROSCIENTIST, V7, P340
  32. Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220
  33. Engel J, 2011, ARCH NEUROL-CHICAGO, V68, P707, DOI 10.1001/archneurol.2011.113
  34. Fang R, 2013, MOL CELL, V49, P558, DOI 10.1016/j.molcel.2012.11.019
  35. Ferraro TN, 2012, PHARMACOGENOMICS, V13, P731, DOI [10.2217/pgs.12.31, 10.2217/PGS.12.31]
  36. Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027
  37. FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7
  38. FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102
  39. Fukata Y, 2010, P NATL ACAD SCI USA, V107, P3799, DOI 10.1073/pnas.0914537107
  40. Gaiteri Chris, 2011, Front Neurosci, V5, P95, DOI 10.3389/fnins.2011.00095
  41. Gao H, 2003, MOL BIOL CELL, V14, P4826, DOI 10.1091/mbc.E03-05-0276
  42. Gehman LT, 2011, NAT GENET, V43, P706, DOI 10.1038/ng.841
  43. Ghiglieri V, 2009, EUR J NEUROSCI, V29, P1979, DOI 10.1111/j.1460-9568.2009.06733.x
  44. Ghiglieri V, 2010, NEUROPSYCHOPHARMACOL, V35, P1531, DOI 10.1038/npp.2010.23
  45. Goldberg EM, 2013, NAT REV NEUROSCI, V14, P337, DOI 10.1038/nrn3482
  46. Gomes C, 2011, J BIOL CHEM, V286, P4357, DOI 10.1074/jbc.M110.170134
  47. GREENGARD L, 1987, J COMPUT PHYS, V73, P325, DOI 10.1016/0021-9991(87)90140-9
  48. Griebel M, 2007, NUMERICAL SIMULATION, P476
  49. Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599
  50. Hallermann S, 2010, NEURON, V68, P710, DOI 10.1016/j.neuron.2010.10.026
  51. Heinrich C, 2011, NEUROBIOL DIS, V42, P35, DOI 10.1016/j.nbd.2011.01.001
  52. Helgager J, 2013, J COMP NEUROL, V521
  53. Hemming K, 2013, COCHRANE DB SYST REV, V1
  54. Herrera F, 2009, CELL DEATH DIFFER, V16, P910, DOI 10.1038/cdd.2009.24
  55. Heverin M, 2012, BRAIN RES, V1480, P81, DOI 10.1016/j.brainres.2012.08.018
  56. Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x
  57. Isaev D, 2007, J NEUROSCI, V27, P11587, DOI 10.1523/JNEUROSCI.2033-07.2007
  58. KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6
  59. Kennard JTT, 2011, NEUROBIOL DIS, V42, P48, DOI 10.1016/j.nbd.2011.01.003
  60. Kim MH, 2009, J NEUROSCI, V29, P1586, DOI 10.1523/JNEUROSCI.4306-08.2009
  61. Kim YH, 2010, STEM CELLS, V28, P1816, DOI 10.1002/stem.511
  62. Kobow K, 2012, EPILEPSIA, V53, P11, DOI 10.1111/epi.12031
  63. Kuzmiski JB, 2001, J NEUROSCI, V21, P8707
  64. Kwon KH, 2013, J PROTEOME RES, V12, P97, DOI 10.1021/pr3008368
  65. Lacey CJ, 2012, J NEUROSCI, V32, P11067, DOI 10.1523/JNEUROSCI.5604-11.2012
  66. Lambert JD, 1992, NUMERICAL METHODS OR, P304
  67. Lawton M, 2010, OXID MED CELL LONGEV, V3, P347, DOI 10.4161/oxim.3.5.13296
  68. Lipovich L, 2012, GENETICS, V192, P1133, DOI 10.1534/genetics.112.145128
  69. Liu Y, 2009, ADV ENZYME REGUL, V49, P75, DOI 10.1016/j.advenzreg.2009.01.006
  70. Liu Y, 2008, MOL BIOL CELL, V19, P3080, DOI 10.1091/mbc.E07-12-1290
  71. Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011
  72. Loeb JA, 2011, NEUROSCI LETT, V497, P205, DOI 10.1016/j.neulet.2011.02.041
  73. Manadas B, 2009, J PROTEOME RES, V8, P4536, DOI 10.1021/pr900366x
  74. Margineanu DG, 2012, EPILEPSY RES, V98, P104, DOI 10.1016/j.eplepsyres.2011.10.006
  75. Masuda N, 2006, SOC NETWORKS, V28, P297, DOI 10.1016/j.socnet.2005.07.005
  76. McAuley JJ, 2007, APPL PHYS LETT, V91, DOI [10.1063/1.2773951, 10.1063/1.27723951]
  77. McBain CJ, 2012, SCIENCE, V338, P482, DOI 10.1126/science.1230338
  78. McClelland S, 2011, NEUROSCI LETT, V497, P155, DOI 10.1016/j.neulet.2011.02.032
  79. McLaughlin D, 2006, GENE EXPR PATTERNS, V6, P394, DOI 10.1016/j.modegep.2005.09.007
  80. McNamara JO, 2012, JASPERS BASIC MECH E
  81. Moriguchi S, 2006, P NATL ACAD SCI USA, V103, P10811, DOI 10.1073/pnas.0509863103
  82. Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107
  83. Muley PD, 2008, DEV NEUROBIOL, V68, P1441, DOI 10.1002/dneu.20670
  84. Musto AE, 2011, EPILEPSIA, V52, P551, DOI 10.1111/j.1528-1167.2010.02920.x
  85. Nguyen MQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041899
  86. Nishi M, 2002, BIOCHEM BIOPH RES CO, V292, P318, DOI 10.1006/bbrc.2002.6649
  87. Nomura DK, 2008, TOXICOL APPL PHARM, V228, P42, DOI 10.1016/j.taap.2007.11.021
  88. Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121
  89. Owuor K, 2009, MOL CELL NEUROSCI, V42, P448, DOI 10.1016/j.mcn.2009.09.008
  90. Pant S, 2009, NAT CELL BIOL, V11, P1399, DOI 10.1038/ncb1986
  91. Parent JM, 2012, JASPERS BASIC MECH E
  92. Park KA, 2011, J NEURAL TRANSM, V118, P433, DOI 10.1007/s00702-010-0490-8
  93. Pavlakis E, 2011, INT J BIOCHEM CELL B, V43, P487, DOI 10.1016/j.biocel.2010.12.016
  94. Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108
  95. Potier S, 2005, EUR J NEUROSCI, V21, P1828, DOI 10.1111/j.1460-9568.2005.04026.x
  96. Prifti E, 2008, BIOINFORMATICS, V24, P2636, DOI 10.1093/bioinformatics/btn492
  97. Qiu C, 2008, J NEUROSCI, V28, P3567, DOI 10.1523/JNEUROSCI.4679-07.2008
  98. Qiu JH, 2010, CELL RES, V20, P908, DOI 10.1038/cr.2010.81
  99. Qureshi IA, 2010, BRAIN RES, V1338, P20, DOI 10.1016/j.brainres.2010.03.110
  100. Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x
  101. Ryan SD, 2012, MOL BIOL CELL, V23, P553, DOI 10.1091/mbc.E11-06-0573
  102. Saeed AI, 2003, BIOTECHNIQUES, V34, P374
  103. Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005
  104. Schneider JW, 2012, ACS CHEM NEUROSCI, V3, P557, DOI 10.1021/cn300025a
  105. Schneider-Mizell CM, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/046008
  106. Schwab MH, 2000, J NEUROSCI, V20, P3714
  107. Schwindinger WF, 2012, J BIOL CHEM, V287, P7121, DOI 10.1074/jbc.M111.308395
  108. Schwindinger WF, 2004, MOL CELL BIOL, V24, P7758, DOI 10.1128/24.17.7758.7768.2004
  109. Shibayama H, 2004, J EXP MED, V199, P581, DOI 10.1084/jem.20031858
  110. Silva AV, 2007, EPILEPTIC DISORD, V9, P438
  111. Silva FN, 2013, J INFORMETR, V7, P469, DOI 10.1016/j.joi.2013.01.007
  112. Stein ELA, 2010, J NEUROCHEM, V113, P42, DOI 10.1111/j.1471-4159.2009.06529.x
  113. Stern S, 2009, J NEUROSCI, V29, P4512, DOI 10.1523/JNEUROSCI.0333-09.2009
  114. Sylwestrak EL, 2012, SCIENCE, V338, P536, DOI 10.1126/science.1222482
  115. Tastet J, 2012, BIOCHEM BIOPH RES CO, V420, P247, DOI 10.1016/j.bbrc.2012.02.134
  116. Tellez-Zenteno JF, 2012, EPILEPSY RES TREAT, V2012
  117. Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605
  118. Uittenbogaard M, 2010, J NEUROSCI RES, V88, P33, DOI 10.1002/jnr.22182
  119. Vellano CP, 2011, TRENDS PHARMACOL SCI, V32, P666, DOI 10.1016/j.tips.2011.07.005
  120. Wagnon JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003067
  121. Waites CL, 2013, EMBO J, V32, P954, DOI 10.1038/emboj.2013.27
  122. Walczak A, 2013, J NEUROSCI, V33, P2507, DOI 10.1523/JNEUROSCI.1085-12.2013
  123. Winden KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020763
  124. Wu YM, 2009, ACTA MED OKAYAMA, V63, P305
  125. Yamada M, 2001, MOL CELL BIOL, V21, P3807, DOI 10.1128/MCB.21.11.3807-3819.2001
  126. Yang Y, 2007, PLOS GENET, V3, P1275, DOI 10.1371/journal.pgen.0030124
  127. Young TR, 2009, INT J BIOCHEM CELL B, V41, P990, DOI 10.1016/j.biocel.2008.06.014
  128. Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059
  129. Zeng SC, 2009, NAT CELL BIOL, V11, P616, DOI 10.1038/ncb1867
  130. Zhang XF, 2010, NAT NEUROSCI, V13, P1056, DOI 10.1038/nn.2610
  131. Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008
  132. Zhu B, 2009, J BIOL CHEM, V284, P3418, DOI 10.1074/jbc.M806717200